Stock PFE PFIZER, INC.
Add to a list
To use this feature you must be a member
Log inSign up
PDF Report : Pfizer, Inc.

Company Pfizer, Inc.

Equities

PFE

US7170811035

Pharmaceuticals

Real-time Estimate Cboe BZX
Other stock markets
 12:17:51 2023-12-07 pm EST 		Intraday chart for Pfizer, Inc. 5-day change 1st Jan Change
28.76 USD -0.12% -5.74% -43.95%
06:04pm Top Stories at Midday: Moody's Downgrades Chinese Banks; AbbVie Acquires Cerevel; Washington to Use March-In Law to Seize Pharma Patents; JetBlue Hikes Outlook MT
04:30pm Biden Administration Launches Measures to Cut Health Care Costs; Proposes Use of 'March-In Rights' for Drugs MT

Business Summary

Pfizer, Inc. the world's leading pharmaceutical group. Net sales break down by family of products as follows:

- vaccines (52.4%);

- drugs for the treatment of cancer (15.2%);

- cardiovascular, metabolic and analgesic drugs (11.5%);

- injectable, anti-infectives drugs and active pharmaceutical ingredients (9%);

- drugs for inflammatory and immune diseases (5.5%);

- drugs for rare diseases (4.4%);

- other (2%).

At the end of 2021, the group had more than 39 production sites worldwide.

Net sales are distributed geographically as follows: the United States (36.6%), Europe (22.6%) and other (40.8%).

Number of employees : 83,000

Sales per Business

USD in Million2021Weight2022Weight Delta
Biopharma
98.7 %
79,557 97.9 % 98,988 98.7 % +24.42%
Other Business Activities
1.3 %
1,731 2.1 % 1,342 1.3 % -22.47%

Sales per region

USD in Million2021Weight2022Weight Delta
United States
42.3 %
29,746 36.6 % 42,473 42.3 % +42.79%
Developed Europe
21.9 %
18,336 22.6 % 21,982 21.9 % +19.88%
Emerging Markets
20.0 %
20,701 25.5 % 20,097 20.0 % -2.92%
Japan
8.0 %
7,316 9.0 % 8,026 8.0 % +9.71%
Developed Rest of World
7.7 %
5,190 6.4 % 7,752 7.7 % +49.35%

Managers

Managers TitleAgeSince
Albert Bourla CEO
 Chief Executive Officer 61 1992
David Denton DFI
 Director of Finance/CFO 58 2022
Lidia Fonseca CTO
 Chief Tech/Sci/R&D Officer 54 -
Mikael Dolsten CTO
 Chief Tech/Sci/R&D Officer 64 2009
Maria Rivas CTO
 Chief Tech/Sci/R&D Officer 59 2022
Jeff Settleman CTO
 Chief Tech/Sci/R&D Officer - 2019
Rady Johnson CMP
 Compliance Officer 62 1993
Aida Habtezion CTO
 Chief Tech/Sci/R&D Officer - 2020
Annaliesa Anderson CTO
 Chief Tech/Sci/R&D Officer - 2006
Christopher J. Stevo IRC
 Investor Relations Contact - 2021

Members of the board

Members of the board TitleAgeSince
Sue Desmond-Hellmann BRD
 Director/Board Member 65 2020
Ronald Blaylock BRD
 Director/Board Member 63 2017
Shantanu Narayen BRD
 Director/Board Member 59 2013
Susan Hockfield BRD
 Director/Board Member 72 2020
Suzanne Johnson BRD
 Director/Board Member 66 2007
Scott Gottlieb BRD
 Director/Board Member 50 2019
James Smith BRD
 Director/Board Member 63 2014
James R. Quincey BRD
 Director/Board Member 58 2020
Joseph Echevarria BRD
 Director/Board Member 66 2015
Albert Bourla CEO
 Chief Executive Officer 61 1992

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 9,562,413,292 5,643,899,525 ( 59.02 %) 3,916,000,000 ( 40.95 %) 59.02 %

Shareholders

NameEquities%Valuation
The Vanguard Group, Inc.
8.593 %
485,168,312 8.593 % 14 827 M $
Wellington Management Co. LLP
3.467 %
195,747,507 3.467 % 5 982 M $
Capital Research & Management Co. (World Investors)
2.996 %
169,140,009 2.996 % 5 169 M $
Geode Capital Management LLC
1.709 %
96,492,866 1.709 % 2 949 M $
Norges Bank Investment Management
1.092 %
61,672,992 1.092 % 1 885 M $
State Farm Investment Management Corp.
0.9654 %
54,508,560 0.9654 % 1 666 M $
Massachusetts Financial Services Co.
0.8743 %
49,364,644 0.8743 % 1 509 M $
Dimensional Fund Advisors LP
0.5775 %
32,605,369 0.5775 % 996 M $
DWS Investment GmbH
0.3917 %
22,115,934 0.3917 % 676 M $
T. Rowe Price Associates, Inc. (Investment Management)
0.3888 %
21,950,090 0.3888 % 671 M $
NameEquities%Valuation
BB Gestão de Recursos DTVM SA
0.002219 %
501,135 0.002219 % 4 M $
Caixa DTVM SA
0.001667 %
376,492 0.001667 % 3 M $
Itaú Unibanco SA
0.000682 %
153,960 0.000682 % 1 M $
Bram Bradesco Asset Management S/A DTVM
0.000278 %
62,748 0.000278 % 478 667 $
XP Allocation Asset Management Ltda.
0.000058 %
13,110 0.000058 % 100 008 $
BTG Pactual WM Gestão de Recursos Ltda.
0.000029 %
6,505 0.000029 % 49 623 $
Inter Asset Gestão de Recursos Ltda.
0.000018 %
4,128 0.000018 % 31 490 $

Holdings

NameEquities%Valuation
PFIZER LIMITED
63.92%
 29,243,042 63.92% 1,383,638,919 $
HALEON PLC
32.00%
 2,955,063,626 32.00% 11,815,289,997 $
LONGBOARD PHARMACEUTICALS, INC.
16.68%
 3,978,540 16.68% 21,543,794 $
PYXIS ONCOLOGY, INC.
16.03%
 7,032,770 16.03% 11,744,726 $
CEREVEL THERAPEUTICS HOLDINGS, INC.
15.43%
 27,349,211 15.43% 646,808,840 $
ALLOGENE THERAPEUTICS, INC.
13.14%
 22,032,040 13.14% 62,130,353 $
ORIC PHARMACEUTICALS, INC.
9.86%
 5,376,344 9.86% 36,021,505 $
HOMOLOGY MEDICINES, INC.
8.65%
 5,000,000 8.65% 5,200,000 $
NEXTCURE, INC.
7.08%
 1,970,759 7.08% 2,029,882 $
VALNEVA SE
6.88%
 9,549,761 6.88% 54,003,421 $

Company contact information

Pfizer Inc.

235 East 42nd Street

10017-5755, New York

+212 733 2323

http://www.pfizer.com
address Pfizer, Inc.(PFE)

Group companies

NameCategory and Sector
Wyeth Holdings LLC
Process Industries - Chemicals: Agricultural
Genetics Institute LLC
Health Technology - Pharmaceuticals: Major
Wyeth Pharmaceuticals LLC
Health Technology - Pharmaceuticals: Major
Thiakis Ltd.
Health Technology - Pharmaceuticals: Major
PFIZER LIMITED
Health Technology - Pharmaceuticals: Major
Pfizer Manufacturing Ireland Unlimited Co.
Health Technology - Pharmaceuticals: Major
Wyeth Consumer Healthcare, Inc.
Health Technology - Pharmaceuticals: Major
Ferrosan ApS
Health Technology - Pharmaceuticals: Other
John Wyeth & Brother Ltd.
Health Technology - Pharmaceuticals: Major

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Pfizer, Inc.

Trading Rating :
Investor Rating :
ESG Refinitiv :
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.79USD
Average target price
40.41USD
Spread / Average Target
+40.37%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
PFIZER, INC. Stock Pfizer, Inc.
-43.95% 163 B $
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+59.95% 530 B $
NOVO NORDISK A/S Stock Novo Nordisk A/S
+42.05% 438 B $
JOHNSON & JOHNSON Stock Johnson & Johnson
-11.67% 377 B $
MERCK & CO., INC. Stock Merck & Co., Inc.
-5.69% 268 B $
ABBVIE INC. Stock AbbVie Inc.
-8.52% 258 B $
ROCHE HOLDING AG Stock Roche Holding AG
-14.13% 230 B $
NOVARTIS AG Stock Novartis AG
+0.79% 200 B $
ASTRAZENECA PLC Stock AstraZeneca PLC
-9.98% 198 B $
AMGEN INC. Stock Amgen Inc.
+3.62% 144 B $
Other Pharmaceuticals
  1. Stock
  2. Equities
  3. Stock Pfizer, Inc. - Nyse
  4. Company Pfizer, Inc.
As early as today, start finding the best investment opportunities!
Optimize my profits
fermer